Dicarba-closo-dodecaboranes/NNS
as/IN
a/DT
pharmacophore/NN
./.
=====
Retinoidal/JJ
antagonists/NNS
and/CC
potential/JJ
agonists/NNS
./.

Synthesis/NN
and/CC
biological/JJ
evaluation/NN
of/IN
the/DT
first/JJ
dicarba-closo-dodecaborane/NN
(/(
carborane/NN
)/)
derivatives/NNS
of/IN
retinoids/NNS
are/VBP
described/VBN
./.
=====
Their/PRP$
retinoidal/JJ
activity/NN
were/VBD
examined/VBN
in/IN
terms/NNS
of/IN
the/DT
differentiation-inducing/JJ
ability/NN
toward/IN
human/JJ
promyelocytic/JJ
leukemia/NN
HL-60/NN
cells/NNS
./.
=====
High/JJ
retinoidal/JJ
activity/NN
(/(
agonist/NN
or/CC
antagonist/NN
for/IN
retinoic/JJ
acid/NN
receptor/NN
(/(
RAR/NN
)/)
requires/VBZ
a/DT
carboxylic/JJ
acid/NN
moiety/NN
and/CC
an/DT
appropriate/JJ
hydrophobic/JJ
group/NN
located/JJ
at/IN
a/DT
suitable/JJ
position/NN
on/IN
the/DT
molecule/NN
./.
=====
The/DT
4-carboranyl-substituted/JJ
compounds/NNS
(7, 11)/NN
showed/VBD
antagonistic/JJ
activity/NN
but/CC
no/DT
agonistic/JJ
activity/NN
even/RB
in/IN
the/DT
presence/NN
of/IN
the/DT
potent/JJ
synergist/NN
HX630/NN
./.
=====
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
3-carboranyl-substituted/JJ
compounds/NNS
(8, 12)/NN
showed/VBD
potential/JJ
agonistic/JJ
activity/NN
,/,
but/CC
no/DT
antagonistic/JJ
activity/NN
./.
=====
The/DT
results/NNS
indicates/VBZ
that/IN
carboranes/NNS
are/VBP
applicable/JJ
as/IN
the/DT
hydrophobic/JJ
moiety/NN
of/IN
biologically/RB
active/JJ
molecules/NNS
./.